Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Neuroimaging. 2018 Jan 10;28(2):173–182. doi: 10.1111/jon.12485

Table 1.

Patient Demographic Data and Pathology

Subjects Age Gender Tumor Type Tumor Location Tumor Volume (mm3)
1 28 F Oligodendroglioma W.H.O. Grade II Right frontal 7,525
2 34 F Recurrent metastatic carcinoma, lung primary Left frontal 5,109
3 57 M Glioblastoma, W.H.O. Grade IV Right parietal 91,683
4 66 F Glioblastoma, W.H.O. Grade IV Left temporal 25,091
5 63 M Metastatic melanoma Right frontal/right temporal/left temporal 28,497
6 52 F Metastatic carcinoma, breast primary Right frontal/right temporo-occipital 3,261
7 70 M Anaplastic astrocytoma, W.H.O. Grade III Left frontal 78,142
8 26 F Anaplastic astrocytoma, W.H.O. Grade III Left frontal 51,825
9 57 F Diffuse astrocytoma W.H.O. Grade II Right frontal 41,062

A total of 9 consecutive patients with brain tumors who had diffusion MRI, T2-weighted, and contrast-enhanced T1-weighted MRI images acquired presurgically were selected. W.H.O. = World Health Organization.